Effect of Functional Power Training on Calf Muscle Length and Strength in Children With Spastic Paresis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age4-18
SponsorAmsterdam UMC, location VUmc

About this trial

Spastic paresis (SP) is a common motor condition in children and is often caused by cerebral palsy. Skeletal muscles develop differently in children with SP due to brain damage in early development; muscle strength and muscle length are reduced compared to typically developing (TD) children. Especially, the calf muscles are affected, which particularly affects their ability to walk and to run, hindering participation in society. There are several treatments aimed to increase the range of motion of the joint by lengthening the muscle, for example botulinum toxin injections. However, these treatments can have a weakening effect on the muscle due to deconditioning from immobilization and due to paralysis.

In rehabilitation centers in the Netherlands functional power training (MegaPower) is offered to children with SP who want to walk and run better. It has been shown that this training improves calf muscle strength and performance during functional walking tests. However, the effect of MegaPower training on muscle morphology (i.a. muscle volume and length) is still unknown. Therefore, the aim of this study is to assess the effect of MegaPower training on the muscle morphology of the medial gastrocnemius in children with SP using 3D ultrasonography. It is expected that MegaPower training results in an increase of muscle volume as well as elongation of the muscle belly. Muscle volume could increase due to hypertrophy of the muscle fibers induced by the training, which could elongate the muscle belly length due to the pennate structure of the medial gastrocnemius. A double-baseline design will be applied for this study with three different measurement times (T0-T1-T2) to compare the training period (12 weeks) with a period (12 weeks) of usual care.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Gross Motor Function Classification System I-III

Children should be able to lie on their stomach for min. one minute

Children should be able to follow instructions.

Disqualifiers

Casting

Botulinum toxin type-A injections

Orthopedic surgery.

Trial population

The children will be recruited from rehabilitations centres in the Netherlands.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Functional power training

    Other intervention

    The training consists of weighted running and walking exercises performed at high-velocity and is given three times a week for 12 weeks.

Treatment groups

23 Participants
are divided into 1 treatment group
Group A: Spastic paresis1 intervention

Trial outcomes

Primary outcomes

1

Muscle volume in dm^3

Time frame
12 weeks before start training (week -12)
2

Muscle volume in dm^3

Time frame
At the start of training (week 0)
3

Muscle volume in dm^3

Time frame
At the end of the training (week 12)
4

Muscle belly length in mm

Time frame
12 weeks before start training (week -12)

Secondary outcomes

1

Isometric muscle strength of the medial gastrocnemius

Measured with a hand-held dynamometer in Nm.

Time frame
At the start of training (week 0)
2

Isometric muscle strength of the medial gastrocnemius

Measured with a hand-held dynamometer in Nm.

Time frame
At the end of the training (week 12)
3

Dynamic muscle strength

Standing heel-rise test on one leg. Measured in amount of repetitions.

Time frame
At the start of training (week 0)
4

Dynamic muscle strength

Standing heel-rise test on one leg. Measured in amount of repetitions.

Time frame
At the end of the training (week 12)

Other outcomes

1

Medical file information

Age, gender, GMFCS-level, medical history

Time frame
12 weeks before start training (week -12)

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Amsterdam UMC, location VUmc

Lead sponsor

Reade Rheumatology Research Institute

Collaborator

University Ghent

Collaborator